MedPath

Accessible Weight Loss for Adults With Low Vision: A Feasibility Study

Not Applicable
Completed
Conditions
Overweight and Obesity
Registration Number
NCT05419063
Lead Sponsor
Towson University
Brief Summary

This study will examine the feasibility of an all-remote approach to enrollment in and implementation of an 8-week weight loss program for adults with low vision. The weight loss program will provide asynchronous support (information, automated texting feedback, tailored emails) for adopting and maintaining lifestyle-based strategies for safe and effective weight loss.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
28
Inclusion Criteria
  • Age ≥18
  • English speaking
  • BMI ≥ 25 and weight < 300lbs (weight limit due to scale limitations)
  • Legally blind
  • Have an email for personal use and ability to check and respond to email daily
  • Have a smart phone with texting for personal use
  • Sufficient internet plan for daily email checking
  • Sufficient phone plan for 12 or more texts per week
  • Ability to send and receive emails and text messages
  • Ability to join a zoom call on a personal phone, tablet, or computer
  • Ability to complete Qualtrics surveys
  • Willing to lose weight through recommended dietary changes, weight tracking and physical activity
  • Interest in one of the specific dietary strategies supported by the text messaging platform
  • Willing to use the study scale with cellular technology to report weights
  • Willing to join an 8-week weight loss program and interested in losing weight
  • Completion of screening, enrollment and baseline data collection
Exclusion Criteria
  • Lost 5% of body weight in the last 6 months
  • Currently participating in a weight loss program or another weight loss study
  • Previously diagnosed eating disorder, or treatment for an eating disorder
  • Pregnant, nursing, or planned pregnancy in the next 6 months
  • Planned weight loss surgery or procedure in the next 6 months
  • Currently using medication for weight loss (prescribed or over the counter)
  • History of cardiovascular events
  • History of type 1 or type 2 diabetes
  • Prescribed medication that might promote weight change such as lithium, steroids, or antipsychotics
  • Medical contraindicate to weight loss (e.g., end-stage renal disease, cancer diagnosis with active/planned treatment)
  • Psychiatric hospitalization in the past 12 months
  • Investigator discretion for safety or to ensure appropriate treatment of study staff

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Usability and helpfulness of program components at week 4week 4

Using descriptive statistics, examine 5-point Likert scale responses for the usability (0 = not at all easy to use; 4= extremely easy to use) and helpfulness (0 = not at all helpful; 4= extremely helpful) of specific program components at week 4.

Secondary Outcome Measures
NameTimeMethod
Usability and helpfulness of program components at week 8week 8

Using descriptive statistics, examine 5-point Likert scale responses for the usability (0 = not at all easy to use; 4= extremely easy to use) and helpfulness (0 = not at all helpful; 4= extremely helpful) of specific program components at week 8.

Program engagement at weeks 4 and 8week 4 and 8

Examine the percentage of weeks with at least one study weight and the percentage of days with responses to dietary tracking at weeks 4 and 8.

Trial Locations

Locations (1)

Towson University

🇺🇸

Towson, Maryland, United States

Towson University
🇺🇸Towson, Maryland, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.